
| 2012 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2011 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2013 | 0 | 4.388.813 | 1.645.648 | 1 | ||
| 2012 | 0 | 6.000.000 | 1.200.000 | 1 | ||
Total number of partners: 8
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 8
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2013-02-01 | Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens | PEACHI | participant | 4.388.813 | 5 |
| 2012-10-01 | A Multi-Stage Malaria Vaccine | MULTIMALVAX | participant | 6.000.000 | 5 |